RANK PATHWAY INHIBITORS IN COMBINATION WITH CDK INHIBITORS
Provided herein are pharmaceutical compositions comprising i) a RANK pathway inhibitor in combination with ii) a CDK inhibitor, and related methods. Provided herein are methods of increasing or restoring a responsiveness or sensitivity of a cancer cell to treatment with a CDK inhibitor and methods o...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English French German |
Published |
09.03.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Provided herein are pharmaceutical compositions comprising i) a RANK pathway inhibitor in combination with ii) a CDK inhibitor, and related methods. Provided herein are methods of increasing or restoring a responsiveness or sensitivity of a cancer cell to treatment with a CDK inhibitor and methods of treating a subject with a resistance or reduced sensitivity to treatment with a CDK inhibitor. |
---|---|
Bibliography: | Application Number: EP20200726977 |